Your Health Plan:
Your Health Plan:
Not SelectedINCRUSE ELLIPTA (umeclidinium bromide) is a brand-name prescription drug for treatment of Chronic Obstructive Airway Disease. INCRUSE ELLIPTA is a anticholinergic. It is available in the form of oral aerosol.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $40-355.
Patient Assistance Prorgams are found:
Other alternatives to INCRUSE ELLIPTA may include:
